{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:07:51Z","timestamp":1788912471414,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54841-1","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:16:24Z","timestamp":1781900184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repurposing trifluridine as an anti-Staphylococcus aureus agent targeting virulence factor staphyloxanthin and attachment genes"],"prefix":"10.1038","volume":"16","author":[{"given":"Supriti","family":"Sandhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhin Poovathumkadavil","family":"Thambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenu","family":"Katoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"54841_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107369","volume":"200","author":"D Cao","year":"2025","unstructured":"Cao, D., Liu, G., Wang, Y. & Xia, X. Repurposing astemizole to kill multidrug-resistant bacteria isolated in general surgery. Microb. Pathog. 200, 107369. https:\/\/doi.org\/10.1016\/j.micpath.2025.107369 (2025).","journal-title":"Microb. Pathog."},{"key":"54841_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14020118","volume":"14","author":"C Ferretti","year":"2025","unstructured":"Ferretti, C. et al. Antimicrobial and antibiofilm activity of auranofin and its two derivatives bearing naproxen and acetylcysteine as ligands against Staphylococci. Antibiotics 14, 118. https:\/\/doi.org\/10.3390\/antibiotics14020118 (2025).","journal-title":"Antibiotics"},{"key":"54841_CR3","unstructured":"World Health Organization. Global Antibiotic Resistance Surveillance Report 2025. https:\/\/www.who.int\/publications\/i\/item\/9789240116337 (2025)."},{"key":"54841_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/molecules31061044","volume":"31","author":"LA Veyna-Hurtado","year":"2026","unstructured":"Veyna-Hurtado, L. A. et al. The difluoroboranyl-fluoroquinolone derivative \u201c7a\u201d inhibits bacterial DNA gyrase and exhibits potent activity against ciprofloxacin-resistant S. aureus in vitro and in vivo using an acute pneumonia model. Molecules 31, 1044. https:\/\/doi.org\/10.3390\/molecules31061044 (2026).","journal-title":"Molecules"},{"key":"54841_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100890","volume":"66","author":"A Upadhayay","year":"2023","unstructured":"Upadhayay, A. et al. Resistance-proof antimicrobial drug discovery to combat global antimicrobial resistance threat. Drug Resist. Updat. 66, 100890. https:\/\/doi.org\/10.1016\/j.drup.2022.100890 (2023).","journal-title":"Drug Resist. Updat."},{"key":"54841_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/npjbiofilms.2015.22","volume":"1","author":"G Feng","year":"2015","unstructured":"Feng, G. et al. Bacterial attachment and biofilm formation on surfaces are reduced by small-diameter nanoscale pores: How small is small enough?. Npj. Biofilms Microbiomes 1, 15022. https:\/\/doi.org\/10.1038\/npjbiofilms.2015.22 (2015).","journal-title":"Npj. Biofilms Microbiomes"},{"key":"54841_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1705814","volume":"25","author":"GM Abebe","year":"2020","unstructured":"Abebe, G. M. The role of bacterial biofilm in antibiotic resistance and food contamination. Int. J. Microbiol. 25, 1705814. https:\/\/doi.org\/10.1155\/2020\/1705814 (2020).","journal-title":"Int. J. Microbiol."},{"key":"54841_CR8","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s12275-017-7274-x","volume":"55","author":"X-H Li","year":"2017","unstructured":"Li, X.-H. & Lee, J.-H. Antibiofilm agents: A new perspective for antimicrobial strategy. J. Microbiol. 55, 753\u2013766 (2017).","journal-title":"J. Microbiol."},{"key":"54841_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12040742","volume":"12","author":"S Esposito","year":"2023","unstructured":"Esposito, S. et al. New antibiotics for Staphylococcus aureus infection: An update from the World Association of Infectious Diseases and Immunological Disorders (WAIDID) and the Italian Society of Anti-Infective Therapy (SITA). Antibiotics 12, 742. https:\/\/doi.org\/10.3390\/antibiotics12040742 (2023).","journal-title":"Antibiotics"},{"key":"54841_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/jambio\/lxaf012","volume":"136","author":"IT Cort\u00eas","year":"2025","unstructured":"Cort\u00eas, I. T., Silva, KdeP. & Cogo-M\u00fcller, K. Effects of simvastatin on the mevalonate pathway and cell wall integrity of Staphylococcus aureus. J. Appl. Microbiol. 136, lxaf012. https:\/\/doi.org\/10.1093\/jambio\/lxaf012 (2025).","journal-title":"J. Appl. Microbiol."},{"key":"54841_CR11","unstructured":"World Health Organization. WHO bacterial priority pathogens list 2024: Bacterial pathogens of public health importance, to guide research, development, and strategies to prevent and control antimicrobial resistance. https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (2024)."},{"key":"54841_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.70293","volume":"19","author":"D Guo","year":"2026","unstructured":"Guo, D. et al. Betulinic acid eradicates implant-associated infections by disrupting the S. aureus biofilm matrix and potentiating host immune clearance. Microb. Biotechnol. 19, e70293. https:\/\/doi.org\/10.1111\/1751-7915.70293 (2026).","journal-title":"Microb. Biotechnol."},{"key":"54841_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/jac\/dkae438","volume":"80","author":"JJ Levenfors","year":"2025","unstructured":"Levenfors, J. J. et al. Repurposing zidovudine and 5-fluoro-2\u2032-deoxyuridine as antibiotic drugs made possible by synergy with both trimethoprim and the mitochondrial toxicity\u2013reducing agent uridine. J. Antimicrob. Chemother. 80, 509\u2013517 (2025).","journal-title":"J. Antimicrob. Chemother."},{"key":"54841_CR14","doi-asserted-by":"crossref","unstructured":"Rudrapal, M., Khairnar, S. J. & Jadhav, A. G. Drug Repurposing (DR): An emerging approach in drug discovery. In Drug Repurposing (ed. Badria, F. A.) Ch. 1 (IntechOpen, 2020).","DOI":"10.5772\/intechopen.93193"},{"key":"54841_CR15","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1080\/09603123.2025.2451623","volume":"35","author":"AS Jarab","year":"2025","unstructured":"Jarab, A. S. et al. Drug repurposing for sustainable antimicrobial use: Exploring pharmacists\u2019 awareness, attitudes, facilitators and barriers. Int. J. Environ. Health Res. 35, 2546\u20132556 (2025).","journal-title":"Int. J. Environ. Health Res."},{"key":"54841_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00952","volume":"10","author":"JM Thomson","year":"2019","unstructured":"Thomson, J. M. & Lamont, I. L. Nucleoside analogues as antibacterial agents. Front. Microbiol. 10, 952. https:\/\/doi.org\/10.3389\/fmicb.2019.00952 (2019).","journal-title":"Front. Microbiol."},{"key":"54841_CR17","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.2174\/1568026622666220317162132","volume":"22","author":"W Zang","year":"2022","unstructured":"Zang, W. et al. The antibacterial potential of ciprofloxacin hybrids against Staphylococcus aureus. Curr. Top. Med. Chem. 22, 1020\u20131034 (2022).","journal-title":"Curr. Top. Med. Chem."},{"key":"54841_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-13-184","volume":"13","author":"R Sun","year":"2013","unstructured":"Sun, R. & Wang, L. Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs. BMC Microbiol. 13, 184. https:\/\/doi.org\/10.1186\/1471-2180-13-184 (2013).","journal-title":"BMC Microbiol."},{"key":"54841_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11030291","volume":"11","author":"L Peyclit","year":"2022","unstructured":"Peyclit, L., Baron, S. A., Hadjadj, L. & Rolain, J. M. In vitro screening of a 1280 FDA-approved drugs library against multidrug-resistant and extensively drug-resistant bacteria. Antibiotics 11, 291. https:\/\/doi.org\/10.3390\/antibiotics11030291 (2022).","journal-title":"Antibiotics"},{"key":"54841_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2024.100180","volume":"7","author":"S Ravishankar","year":"2024","unstructured":"Ravishankar, S. et al. Fluoropyrimidines affect de novo pyrimidine synthesis impairing biofilm formation in Escherichia coli. Biofilm 7, 100180. https:\/\/doi.org\/10.1016\/j.bioflm.2024.100180 (2024).","journal-title":"Biofilm"},{"key":"54841_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-020-03112-1","volume":"20","author":"G Singh","year":"2020","unstructured":"Singh, G. & Katoch, M. Antimicrobial activities and mechanism of action of Cymbopogon khasianus (Munro ex Hackel) bor essential oil. BMC Complement. Med. Ther. 20, 331. https:\/\/doi.org\/10.1186\/s12906-020-03112-1 (2020).","journal-title":"BMC Complement. Med. Ther."},{"key":"54841_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25235643","volume":"25","author":"BH Gan","year":"2020","unstructured":"Gan, B. H., Cai, X., Javor, S., K\u00f6hler, T. & Reymond, J. L. Synergistic effect of propidium iodide and small molecule antibiotics with the antimicrobial peptide dendrimer g3kl against gram-negative bacteria. Molecules 25, 5643. https:\/\/doi.org\/10.3390\/molecules25235643 (2020).","journal-title":"Molecules"},{"key":"54841_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50207-y","volume":"9","author":"A Valliammai","year":"2019","unstructured":"Valliammai, A. et al. 5-Dodecanolide interferes with biofilm formation and reduces the virulence of Methicillin-resistant Staphylococcus aureus (MRSA) through up regulation of agr system. Sci. Rep. 9, 13744. https:\/\/doi.org\/10.1038\/s41598-019-50207-y (2019).","journal-title":"Sci. Rep."},{"key":"54841_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcab.2023.102894","volume":"54","author":"P Rani","year":"2023","unstructured":"Rani, P., Nidhin, P. T., Ali, S. M., Bera, A. & Katoch, M. The antifungal mechanism of Monarda citriodora essential oil, hexanal and their combined vapours on Aspergillus foetidus. Biocatal. Agric. Biotechnol. 54, 102894. https:\/\/doi.org\/10.1016\/j.bcab.2023.102894 (2023).","journal-title":"Biocatal. Agric. Biotechnol."},{"key":"54841_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21091194","volume":"21","author":"JG Xu","year":"2016","unstructured":"Xu, J. G., Liu, T., Hu, Q. P. & Cao, X. M. Chemical composition, antibacterial properties and mechanism of action of essential oil from clove buds against Staphylococcus aureus. Molecules 21, 1194. https:\/\/doi.org\/10.3390\/molecules21091194 (2016).","journal-title":"Molecules"},{"key":"54841_CR26","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41429-022-00508-8","volume":"75","author":"G Singh","year":"2022","unstructured":"Singh, G. et al. Synergistic antimicrobial and antibiofilm activities of piperic acid and 4-ethylpiperic acid amides in combination with ciprofloxacin. J. Antibiot. 75, 236\u2013242 (2022).","journal-title":"J. Antibiot."},{"key":"54841_CR27","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1016\/S0142-9612(02)00171-0","volume":"23","author":"CR Arciola","year":"2002","unstructured":"Arciola, C. R. et al. Detection of slime production by means of an optimised Congo Red agar plate test based on a colourimetric scale in Staphylococcus epidermidis clinical isolates genotyped for ica locus. Biomaterials 23, 4233\u20134239 (2002).","journal-title":"Biomaterials"},{"key":"54841_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-015-0440-6","volume":"15","author":"SK Giles","year":"2015","unstructured":"Giles, S. K., Stroeher, U. H., Eijkelkamp, B. A. & Brown, M. H. Identification of genes essential for pellicle formation in Acinetobacter baumannii. BMC Microbiol. 15, 116. https:\/\/doi.org\/10.1186\/s12866-015-0440-6 (2015).","journal-title":"BMC Microbiol."},{"key":"54841_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22929-z","volume":"12","author":"J-A Cho","year":"2022","unstructured":"Cho, J.-A. et al. Assessment of the biofilm-forming ability on solid surfaces of periprosthetic infection-associated pathogens. Sci. Rep. 12, 18669. https:\/\/doi.org\/10.1038\/s41598-022-22929-z (2022).","journal-title":"Sci. Rep."},{"key":"54841_CR30","first-page":"193","volume":"12","author":"AD Gandhi","year":"2017","unstructured":"Gandhi, A. D. et al. In vitro anti- biofilm and antibacterial activity of Sesbania grandiflora extract against Staphylococcus aureus. Biochem. Biophys. Rep. 12, 193\u2013197 (2017).","journal-title":"Biochem. Biophys. Rep."},{"key":"54841_CR31","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s13213-013-0618-9","volume":"63","author":"K Jain","year":"2013","unstructured":"Jain, K., Parida, S., Mangwani, N., Dash, H. R. & Das, S. Isolation and characterization of biofilm-forming bacteria and associated extracellular polymeric substances from oral cavity. Ann. Microbiol. 63, 1553\u20131562 (2013).","journal-title":"Ann. Microbiol."},{"key":"54841_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2015.00123","volume":"3","author":"S Jachlewski","year":"2015","unstructured":"Jachlewski, S. et al. Isolation of extracellular polymeric substances from biofilms of the thermoacidophilic archaeon Sulfolobus acidocaldarius. Front. Bioeng. Biotechnol. 3, 123. https:\/\/doi.org\/10.3389\/fbioe.2015.00123 (2015).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"54841_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.937970","volume":"13","author":"N Singh","year":"2022","unstructured":"Singh, N. et al. HupB, a nucleoid-associated protein, is critical for survival of Mycobacterium tuberculosis under host-mediated stresses and for enhanced tolerance to key first-line antibiotics. Front. Microbiol. 13, 937970. https:\/\/doi.org\/10.3389\/fmicb.2022.937970 (2022).","journal-title":"Front. Microbiol."},{"key":"54841_CR34","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1021\/acsinfecdis.9b00305","volume":"6","author":"C Oe","year":"2020","unstructured":"Oe, C. et al. Pyrimidine analogues as a new class of gram-positive antibiotics, mainly targeting thymineless-death related proteins. ACS Infect. Dis. 6, 1490\u20131500 (2020).","journal-title":"ACS Infect. Dis."},{"key":"54841_CR35","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/jac\/dkx151","volume":"72","author":"AEJ Yssel","year":"2017","unstructured":"Yssel, A. E. J., Vanderleyden, J. & Steenackers, H. P. Repurposing of nucleoside- and nucleobase-derivative drugs as antibiotics and biofilm inhibitors. J. Antimicrob. Chemother. 72, 2156\u20132170 (2017).","journal-title":"J. Antimicrob. Chemother."},{"key":"54841_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11030298","volume":"11","author":"RA Elmesseri","year":"2022","unstructured":"Elmesseri, R. A., Saleh, S. E., Elsherif, H. M., Yahia, I. S. & Aboshanab, K. M. Staphyloxanthin as a potential novel target for deciphering promising anti-Staphylococcus aureus agents. Antibiotics. 11, 298. https:\/\/doi.org\/10.3390\/antibiotics11030298 (2022).","journal-title":"Antibiotics."},{"key":"54841_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12101956","volume":"12","author":"A Tyagi","year":"2024","unstructured":"Tyagi, A., Kumar, V., Joshi, N. & Dhingra, H. K. Combinatorial effects of ursodeoxycholic acid and antibiotic in combating Staphylococcus aureus biofilm: The roles of ROS and virulence factors. Microorganisms 12, 1956. https:\/\/doi.org\/10.3390\/microorganisms12101956 (2024).","journal-title":"Microorganisms"},{"key":"54841_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/jambio\/lxad292","volume":"134","author":"N Poovathumkadavil Thambi","year":"2023","unstructured":"Poovathumkadavil Thambi, N., Rani, P., Sharma, M. & Katoch, M. A combinatorial approach of Monarda citriodora essential oil (MEO) and linalool vapors to control fruit rot of Citrus limon caused by a new pathogen, Aspergillus foetidus, and its underlying mode of action. J. Appl. Microbiol. 134, lxad292. https:\/\/doi.org\/10.1093\/jambio\/lxad292 (2023).","journal-title":"J. Appl. Microbiol."},{"key":"54841_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24224104","volume":"24","author":"K Zawadzka","year":"2019","unstructured":"Zawadzka, K., Nowak, M., Piwo\u0144ski, I. & Lisowska, K. The synergy of ciprofloxacin and carvedilol against Staphylococcus aureus-Prospects of a new treatment strategy?. Molecules 24, 4104. https:\/\/doi.org\/10.3390\/molecules24224104 (2019).","journal-title":"Molecules"},{"key":"54841_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07541-z","volume":"16","author":"M Huang","year":"2025","unstructured":"Huang, M. et al. Trifluridine\/tipiracil induces ferroptosis by targeting p53 via the p53-SLC7A11 axis in colorectal cancer 3D organoids. Cell Death Dis 16, 255. https:\/\/doi.org\/10.1038\/s41419-025-07541-z (2025).","journal-title":"Cell Death Dis"},{"key":"54841_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ani14091286","volume":"14","author":"J Zuo","year":"2024","unstructured":"Zuo, J. et al. Tackling antibiotic resistance: Exploring 5-fluorouracil as a promising antimicrobial strategy for the treatment of Streptococcus suis infection. Animals 14, 1286. https:\/\/doi.org\/10.3390\/ani14091286 (2024).","journal-title":"Animals"},{"key":"54841_CR42","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/S0006-291X(02)02331-8","volume":"297","author":"MC Becerra","year":"2002","unstructured":"Becerra, M. C. & Albesa, I. Oxidative stress induced by ciprofloxacin in Staphylococcus aureus. Biochem. Biophys. Res. Commun. 297, 1003\u20131007 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"54841_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13060528","volume":"13","author":"M Zhang","year":"2024","unstructured":"Zhang, M. et al. Deciphering the antibacterial mechanisms of 5-Fluorouracil in Escherichia coli through biochemical and transcriptomic analyses. Antibiotics 13, 528. https:\/\/doi.org\/10.3390\/antibiotics13060528 (2024).","journal-title":"Antibiotics"},{"key":"54841_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF02976431","volume":"22","author":"D Kim","year":"1999","unstructured":"Kim, D., Lee, I. S., Jung, J. H. & Yang, S.-I. Psammaplin A, a natural bromotyrosine derivative from a sponge, possesses the antibacterial activity against methicillin-resistant Staphylococcus aureus and the DNA gyrase-inhibitory activity. Arch. Pharm. Res. 22, 25\u201329 (1999).","journal-title":"Arch. Pharm. Res."},{"key":"54841_CR45","doi-asserted-by":"crossref","unstructured":"Meng, Y., Zhang, T., Sun, N., Yu, B. & Chang, J. Nucleosides with fluorinated nucleobases for antiviral and anticancer therapies. Fundam Res. (2025)","DOI":"10.1016\/j.fmre.2025.06.002"},{"key":"54841_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2026.109716","volume":"174","author":"SM Bellapukonda","year":"2026","unstructured":"Bellapukonda, S. M. et al. Exploration of 1,3-di substituted pyrazole conjugates as DNA gyrase inhibitors to combat Staphylococcus aureus and Mycobacterium tuberculosis. Bioorg. Chem. 174, 109716. https:\/\/doi.org\/10.1016\/j.bioorg.2026.109716 (2026).","journal-title":"Bioorg. Chem."},{"key":"54841_CR47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000063872","volume":"48","author":"A Nyhl\u00e9n","year":"2002","unstructured":"Nyhl\u00e9n, A., Ljungberg, B., Nilsson-Ehle, I. & Odenholt, I. Postantibiotic effect of meropenem and ciprofloxacin in the presence of 5-Fluorouracil. Chemotherapy 48, 182\u2013188 (2002).","journal-title":"Chemotherapy"},{"key":"54841_CR48","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1099\/00222615-26-3-229","volume":"26","author":"TSJ Elliott","year":"1988","unstructured":"Elliott, T. S. J., D\u2019Abrera, V. C. & Dutton, S. The effect of antibiotics on bacterial colonisation of vascular cannulae in a novel in-vitro model. J. Med. Microbiol. 26, 229\u2013235 (1988).","journal-title":"J. Med. Microbiol."},{"key":"54841_CR49","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5114\/ada.2020.94837","volume":"37","author":"A Chmielowiec-Korzeniowska","year":"2020","unstructured":"Chmielowiec-Korzeniowska, A., Tymczyna, L., Wlaz\u0142o, \u0141, Nowakowicz-D\u0119bek, B. & Trawi\u0144ska, B. Staphylococcus aureus carriage state in healthy adult population and phenotypic and genotypic properties of isolated strains. Postepy Dermatol. Alergol. 37, 184\u2013189 (2020).","journal-title":"Postepy Dermatol. Alergol."},{"key":"54841_CR50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00005-010-0079-9","volume":"58","author":"A Podbielska","year":"2010","unstructured":"Podbielska, A., Galkowska, H., Stelmach, E., Mlynarczyk, G. & Olszewski, W. L. Slime production by Staphylococcus aureus and Staphylococcus epidermidis strains isolated from patients with diabetic foot ulcers. Arch. Immunol. Ther. Exp. (Warsz) 58, 321\u2013324 (2010).","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"54841_CR51","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ijantimicag.2007.01.007","volume":"29","author":"D Wojnicz","year":"2007","unstructured":"Wojnicz, D. & Jankowski, S. Effects of subinhibitory concentrations of amikacin and ciprofloxacin on the hydrophobicity and adherence to epithelial cells of uropathogenic Escherichia coli strains. Int. J. Antimicrob. Agents. 29, 700\u2013704 (2007).","journal-title":"Int. J. Antimicrob. Agents."},{"key":"54841_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2020.151410","volume":"310","author":"P Dey","year":"2020","unstructured":"Dey, P., Parai, D., Banerjee, M., Hossain, S. T. & Mukherjee, S. K. Naringin sensitizes the antibiofilm effect of ciprofloxacin and tetracycline against Pseudomonas aeruginosa biofilm. Int. J. Med. Microbiol. 310, 151410. https:\/\/doi.org\/10.1016\/j.ijmm.2020.151410 (2020).","journal-title":"Int. J. Med. Microbiol."},{"key":"54841_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9946183","volume":"2021","author":"M Mombeshora","year":"2021","unstructured":"Mombeshora, M., Chi, G. F. & Mukanganyama, S. Antibiofilm activity of extract and a compound isolated from Triumfetta welwitschii against Pseudomonas aeruginosa. Biochem. Res. Int. 2021, 9946183. https:\/\/doi.org\/10.1155\/2021\/9946183 (2021).","journal-title":"Biochem. Res. Int."},{"key":"54841_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.biortech.2022.127098","volume":"352","author":"Z Liu","year":"2022","unstructured":"Liu, Z., Sun, X. & Sun, Z. Degradation mechanism of montmorillonite-enhanced antibiotic wastewater: Performance, antibiotic resistance genes, microbial communities, and functional metabolism. Bioresour. Technol. 352, 127098. https:\/\/doi.org\/10.1016\/j.biortech.2022.127098 (2022).","journal-title":"Bioresour. Technol."},{"key":"54841_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1328947","volume":"14","author":"ZX Luo","year":"2023","unstructured":"Luo, Z. X., Li, Y., Liu, M. F. & Zhao, R. Ciprofloxacin enhances the biofilm formation of Staphylococcus aureus via an agrC-dependent mechanism. Front. Microbiol. 14, 1328947. https:\/\/doi.org\/10.3389\/fmicb.2023.1328947 (2023).","journal-title":"Front. Microbiol."},{"key":"54841_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-016-0791-7","volume":"16","author":"A Jo","year":"2016","unstructured":"Jo, A. & Ahn, J. Phenotypic and genotypic characterisation of multiple antibiotic-resistant Staphylococcus aureus exposed to subinhibitory levels of oxacillin and levofloxacin. BMC. Microbiol. 16, 170. https:\/\/doi.org\/10.1186\/s12866-016-0791-7 (2016).","journal-title":"BMC. Microbiol."},{"key":"54841_CR57","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1128\/AAC.00155-09","volume":"54","author":"S Karen","year":"2010","unstructured":"Karen, S. et al. Influence of tigecycline on expression of virulence factors in biofilm-associated cells of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 54, 380\u2013387 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"54841_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.825041","volume":"13","author":"Z Ren","year":"2022","unstructured":"Ren, Z. et al. A general map of transcriptional expression of virulence, metabolism, and biofilm formation adaptive changes of Staphylococcus aureus when exposed to different antimicrobials. Front. Microbiol. 13, 825041. https:\/\/doi.org\/10.3389\/fmicb.2022.825041 (2022).","journal-title":"Front. Microbiol."},{"key":"54841_CR59","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1128\/JCM.01425-07","volume":"46","author":"H Muzaffar","year":"2008","unstructured":"Muzaffar, H. et al. Eap gene as novel target for specific identification of Staphylococcus aureus. J. Clin. Microbiol. 46, 470\u2013476 (2008).","journal-title":"J. Clin. Microbiol."},{"key":"54841_CR60","doi-asserted-by":"publisher","first-page":"e01643","DOI":"10.1128\/AEM.01643-17","volume":"83","author":"M Slany","year":"2017","unstructured":"Slany, M., Oppelt, J. & Cincarova, L. Formation of Staphylococcus aureus biofilm in the presence of sublethal concentrations of disinfectants studied via a transcriptomic analysis using transcriptome sequencing (RNA-seq). Appl. Environ. Microbiol. 83, e01643-e1717. https:\/\/doi.org\/10.1128\/AEM.01643-17 (2017).","journal-title":"Appl. Environ. Microbiol."},{"key":"54841_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1584479","volume":"16","author":"AA Niazy","year":"2025","unstructured":"Niazy, A. A., Alrashed, M. M. & Niazy, A. A. Effect of 5-fluorouracil on Pseudomonas aeruginosa: Impact on virulence, biofilm formation, and bacterial growth. Front. Microbiol. 16, 1584479. https:\/\/doi.org\/10.3389\/fmicb.2025.1584479 (2025).","journal-title":"Front. Microbiol."},{"key":"54841_CR62","first-page":"e03412","volume":"12","author":"P Ki-Ho","year":"2024","unstructured":"Ki-Ho, P. et al. Effects of sub-inhibitory concentrations of nafcillin, vancomycin, ciprofloxacin, and rifampin on biofilm formation of clinical methicillin-resistant Staphylococcus aureus. Microbiol. Spectr. 12, e03412-e3423 (2024).","journal-title":"Microbiol. Spectr."},{"key":"54841_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11090995","volume":"11","author":"NAS Neto","year":"2022","unstructured":"Neto, N. A. S. et al. Synergistic antibiofilm activity between synthetic peptides and ciprofloxacin against Staphylococcus aureus. Pathogens 11, 995. https:\/\/doi.org\/10.3390\/pathogens11090995 (2022).","journal-title":"Pathogens"},{"key":"54841_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5544","volume":"10","author":"M Shibutani","year":"2022","unstructured":"Shibutani, M. et al. Severe pancytopenia caused by trifluridine\/tipiracil in patients with metastatic colorectal cancer and an impaired renal function: A case report. Clin. Case Rep. 10, e05544. https:\/\/doi.org\/10.1002\/ccr3.5544 (2022).","journal-title":"Clin. Case Rep."},{"key":"54841_CR65","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1191\/0960327102ht305oa","volume":"21","author":"A G\u00fcrbay","year":"2002","unstructured":"G\u00fcrbay, A. et al. Cytotoxicity in ciprofloxacin-treated human fibroblast cells and protection by vitamin E. Hum. Exp. Toxicol. 21, 635\u2013641 (2002).","journal-title":"Hum. Exp. Toxicol."},{"key":"54841_CR66","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/15401420390271083","volume":"1","author":"F Hincal","year":"2003","unstructured":"Hincal, F., G\u00fcrbay, A. & Favier, A. Biphasic response of ciprofloxacin in human fibroblast cell cultures. Nonlinearity Biol. Toxicol. Med. 1, 481\u2013492 (2003).","journal-title":"Nonlinearity Biol. Toxicol. Med."},{"key":"54841_CR67","first-page":"507","volume":"10","author":"J Li","year":"2020","unstructured":"Li, J. et al. Trifluridine selectively inhibits cell growth and induces cell apoptosis of triple-negative breast cancer. Am. J. Cancer Res. 10, 507\u2013522 (2020).","journal-title":"Am. J. Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54841-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54841-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54841-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:46:03Z","timestamp":1788911163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54841-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54841"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54841-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28194"}}